Vimarsana
Biggest News Aggregation in the World

Muckle Wells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Muckle Wells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Muckle Wells Today - Breaking & Trending Today

Oxford 12-year-old joins research programme for rare disease - Vimarsana News

Oxford 12-year-old joins research programme for rare disease

A girl from Oxford who is suffering from a rare autoinflammatory disease has joined a national programme aiming to further studies into similar…

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases - Vimarsana News

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

<ul> <li> Secarna's LNAplus™ ASOs suppress expression of NLRP3, a central component of the inflammasome pathway, which is overactive in many inflammatory diseases </li> <li> Cryopyrin-associated periodic syndrome (CAPS) is a group of rare inherited autoinflammatory diseases driven by overactive NLRP3, resulting in systemic inflammation </li> <li> With NLRP3-specific ASOs, inflammatory downstream effects were interrupted in immune cells and strong symptom relief and significant prolongation of survival was achieved in a CAPS disease mo...

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus&#x2122; ASO targeting NLRP3 in highly debilitating autoinflammatory diseases - Vimarsana News

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus&#x2122; ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

LiveNews Provides news reports of information as it happens in real time of politics, business, the economy and also reports on global issues and events from a New Zealand viewpoint.

The first case of NLRP3-AID in Ecuador - Vimarsana News

The first case of NLRP3-AID in Ecuador

A 9-year-old patient with recurrent fever, urticarial rash and demyelinating brain lesions: nlrp3- autoinflammatory disease in Ecuador